✨ Free AI Report
Ocata Therapeutics: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Ocata Therapeutics
Research Preview

Ocata Therapeutics: Business Overview, Financials & Competitive Analysis

Ocata Therapeutics is a subsidiary of Astellas Pharma focused on regenerative ophthalmology and stem cell therapies for retinal diseases. The company develops cell therapy treatments targeting macular degenerative con...

Analyst-debate audio for Ocata Therapeutics

AskCyborg analysts argue the bull and bear cases for Ocata Therapeutics across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Ocata Therapeutics OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Ocata's deep expertise in pluripotent stem cell therapy and position within Astellas provides credibility and resources, but...

Read the full analyst-debate transcript →
Industry Regenerative Medicine / Cell Therapy
2 named competitors
1 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 6, 2026
AI-Verified Research
30+ Page Report

Get the Latest Ocata Therapeutics Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Ocata Therapeutics Overview

Pro stress-test →

Ocata Therapeutics is a subsidiary of Astellas Pharma focused on regenerative ophthalmology and stem cell therapies for retinal diseases. The company develops cell therapy treatments targeting macular degenerative conditions including Dry AMD, Stargardt disease, and myopic macular degeneration.

Strategic Profile

Pro stress-test →

Ocata leverages proprietary pluripotent stem cell platforms (human embryonic stem cells and induced pluripotent stem cells) to address significant unmet medical needs in ophthalmology. Following its acquisition by Astellas in (February 2016) for $379 million, the company operates as Astellas' regenerative ophthalmology innovation center with clinical-stage pipeline programs.

Competitive Landscape

Pro stress-test →

Ocata competes in the regenerative ophthalmology and cell therapy space with other companies developing stem cell treatments for retinal diseases. Key competitive areas include pluripotent stem cell platforms and clinical-stage cell therapies for macular degeneration and related ocular disorders.

Industry Context

Ocata Therapeutics operates in Regenerative Medicine / Cell Therapy.

Key facts

Founded: 1994 · Headquarters: Marlborough, US

What the analysts stress-tested

The top findings that survived the multi-agent debate for Ocata Therapeutics.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Ocata Therapeutics has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Regenerative Medicine Advanced TherapiesCell and gene therapy approaches for ophthalmology→Cell Therapy ProgramsRegenerative medicine and cell-based treatments→

Compare Ocata Therapeutics with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Ocata Therapeutics operates in Regenerative Medicine / Cell Therapy. See how the rest of the sector scores on the Cyborg framework.

Browse Regenerative Medicine / Cell Therapy research →
NEW · MCP server

Ask your AI assistant about Ocata Therapeutics

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Ocata Therapeutics and its top competitor on Cyborg Score”
“What did Ocata Therapeutics do this quarter?”
“Is Ocata Therapeutics a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Ocata Therapeutics do?+
Ocata Therapeutics is a subsidiary of Astellas Pharma focused on regenerative ophthalmology and stem cell therapies for retinal diseases. The company develops cell therapy treatments targeting macular degenerative con...
What is Ocata Therapeutics's Cyborg Score?+
Ocata Therapeutics has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Ocata Therapeutics's main competitors?+
Named competitors include Regenerative Medicine Advanced Therapies, Cell Therapy Programs. The full competitive landscape is in the AskCyborg report.
How can I get the full Ocata Therapeutics research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Ocata Therapeutics research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Ocata Therapeutics over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9GELEX Group Joint Stock Company9TTM Technologies, Inc.9Insulet Corporation9Marathon Petroleum Corporation9Seagate Technology Holdings plc9Howmet Aerospace Inc.9Investor AB9Micron Technology, Inc.9Taiwan Semiconductor Manufacturing Company Limited9NVIDIA Corporation8NIO Inc.8Seanergy Maritime Holdings Corp.8Grupo Aeroméxico, S.A.B. de C.V.8Gulf Medical Projects Company8Interloop Limited8Kyverna Therapeutics, Inc.8Tatton Asset Management Plc8Invictus Investment Company PLC